Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - WIERENGA WENDALL
Last Updated 
6-May-16
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

WIERENGA WENDALL: Declared Holdings
Company/RelationshipReportedShares  Ownership
Anacor Pharmaceuticals, Inc.
Director
NasdaqGM:ANAC
(historical quotes, profile, other insiders)
9-Jun-15794  Direct
Apricus Biosciences, Inc
Director
NasdaqCM:APRI
(historical quotes, profile, other insiders)
22-Oct-14
5-Apr-16
20,000
   24,850
44,850
  Direct
  Indirect  
  Total
Ocera Therapeutics, Inc.
Director
NasdaqGM:OCRX
(historical quotes, profile, other insiders)
23-Jun-155,000  Direct
XenoPort, Inc.
Director
NasdaqGS:XNPT
(historical quotes, profile, other insiders)
19-May-1533,998  Direct

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
5-Apr-16 *4,850APRI Acquisition (Non Open Market) at $0.58 - $0.58 per share.
(Value of about $2,813)
23-Jun-15 5,000OCRX Purchase at $3.71 - $3.71 per share.
(Cost of about $19,000)
9-Jun-15 794ANAC Acquisition (Non Open Market) at $0 per share.
19-May-15 5,000XNPT Option Exercise at $0 per share.
11-May-15 5,000XNPT Purchase at $5.63 - $5.63 per share.
(Cost of about $28,000)
22-Oct-14 20,000APRI Purchase at $1.52 - $1.52 per share.
(Cost of about $30,000)
27-May-14 10,000XNPT Purchase at $3.99 - $3.99 per share.
(Cost of about $40,000)
14-May-14 5,000XNPT Option Exercise at $0 per share.

 

 

    * Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)



EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?